Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

American Journal of Kidney Diseases

Volumn 34, Issue 1, 1999, Pages 125-134

  Levin, A ^a   Thompson, C R ^a   Ethier, J ^a   Carlisle, E J F ^a   Tobe, S ^a   Mendelssohn, D ^a   Burgess, E ^a   Jindal, K ^a   Barrett, B ^a   Singer, J ^a   Djurdjev, O ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Anemia; Cardiovascular risk; Growth; Left ventricular hypertrophy; Left ventricular mass; Predialysis

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0033053766     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70118-6     Document Type: Article

References (37)

1. Canadian Organ Replacement Registry Report: Hospital Medical Records Institute 1997 Don Mills, Canada Ontario
2. P Parfrey S Griffiths J Harnett R Taylor A King J Hand P Barre Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease and ischemic heart disease in dialysis patients Am J Nephrol 10 1990 213 221
3. JD Harnett GM Kent PE Barre R Taylor PS Parfrey Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients J Am Soc Nephrol 4 1994 1486 1490
4. PS Parfrey RN Foley JD Harnett GM Kent DC Murray PE Barre Outcome and risk factors for left ventricular disorders in chronic uraemia Nephrol Dial Transplant 11 1996 1277 1285
5. V Dzau The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes Curr Opin Nephrol Hypertens 2 1993 27 32
6. D Ganten F Luft K Kurokawa Hormones, autocoids, neurotransmitters, and growth factors Curr Opin Nephrol Hypertens 2 1993 1 4
7. S Sen Factors regulating myocardial hypertrophy in hypertension Circulation 75 1987 I81 I84
8. G Mall M Rambansek A Neumeister S Kollmar F Vetterlein E Ritz Myocardial interstitial fibrosis in experimental uremia: Implications for cardiac compliance Kidney Int 33 1988 804 811
9. A Levin J Singer C Thompson M Ross M Lewis Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention Am J Kidney Dis 27 1996 347 354
10. J Silberberg N Racine P Barre A Sniderman Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin Can J Cardiol 6 1990 1 4
11. RN Foley PS Parfrey JD Harnett GM Kent CJ Martin DC Murray PE Barre Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
12. B Dahlof K Pennert L Hansson Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies Am J Hypertens 5 1992 95 110
13. A Sniderman J Silberberg S Prichard P Barre Anemia and left ventricular function in end-stage renal disease P Parfrey J Harnett Cardiac Dysfunction in Chronic Uremia 1992 Kluwer Academic Boston, MA 161 171
14. D Cockroft M Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
15. J Rutherford E Braunwald Chronic ischemic heart disease E Braunwald Heart Disease 1992 Saunders Philadelphia, PA chap 40
16. RB Devereux TG Pickering MH Alderman S Chien JS Borer JH Laragh Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables Hypertension 9 1987 1153 1160
17. HW Collins Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography J Am Coll Cardiol 14 1989 672 676
18. JS Gottdiener SV Livengood PS Meyer GA Chase Should echocardiography be performed in individual patients to assess LV regression? Test-retest reliability of echocardiography for measurement of left ventricular mass J Am Coll Cardiol 21 1993 424 430
19. WF Heeson FW Beltman AJ Smit JF May A simple nomogram for determination of echocardiographic left ventricular geometry Am J Cardiol 82 1998 485 489
20. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
21. E Vaughan Williams Ventricular hypertrophy—Physiologic mechanisms J Cardiovasc Pharmacol 8 1986 S12 S16 (suppl 3)
22. G Olivetti C Lagrasta F Quaini R Ricci G Moccia JM Capasso P Anversa Capillary growth in anemia-induced ventricular wall remodeling in the rat heart Circ Res 65 1989 1182 1192
23. KW Scheel E Seavey JF Gaugl SE Williams Coronary and myocardial adaptations to high altitude in dogs Am J Physiol 259 1990 H1173 H1667
24. G Olivetti F Quaini C Lagrasta R Ricci P Tosini JM Capasso P Anversa Effects of genetic hypertension and nutritional anaemia on ventricular remodelling and myocardial damage in rats Cardiovasc Res 27 1993 1316 1325
25. Z Tanne R Coleman M Nahir D Shomrat JP Finberg MB Youdim Ultrastructural and cytochemical changes in the heart of iron-deficient rats Biochem Pharmacol 47 1994 1759 1766
26. RN Re Cellular mechanisms of growth in cardiovascular tissue Am J Cardiol 60 1987 104I 109I
27. PT Stockmann DH Will SD Sides SR Brunnert GD Wilner KM Leahy RC Wiegand P Needleman Reversible induction of right ventricular atriopeptin synthesis in hypertrophy due to hypoxia Circ Res 63 1988 207 213
28. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions [published erratum N Engl J Med 327:1768, 1992] N Engl J Med 327 1992 685 691
29. MA Pfeffer E Braunwald LA Moye L Basta EJ Brown Jr TE Cuddy BR Davis EM Geltman S Goldman GC Flaker M Klein GA Lamas M Packer J Rouleau JL Rouleau J Rutherford JH Wertheimer CM Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
30. RE Schmeider MP Schlaich AU Klingbeil P Martus Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double blind studies until December 1996) Nephrol Dial Trans 13 1998 564 569
31. DV Vlahakos VJ Canzanello MP Madaio NE Madias Enalapril-associated anemia in renal transplant recipients treated for hypertension Am J Kidney Dis 17 1991 199 205
32. JV Torregrosa JM Campistol M Montesinos AG Rogada F Oppenheimer J Andreu Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up Transplantation 58 1994 311 314
33. GM Danovitch NJ Jamgotchian PH Eggena W Paul JD Barrett A Wilkinson DB Lee Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism Transplantation 60 1995 132 137
34. E Lewis The effect of angiotensin-converting enzyme inhibitors on diabetic nephropathy N Engl J Med 329 1993 1459 1462
35. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre The prognostic importance of left ventricular geometry in uremic cardiomyopathy J Am Soc Nephrol 5 1995 2024 2031
36. JD Harnett GM Kent RN Foley PS Parfrey Cardiac function and hematocrit level Am J Kidney Dis 25 1995 S3 S7 (suppl 4)
37. D Levy RH Garrison D Savage WB Kannell WP Castelli Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566